tiprankstipranks
Trending News
More News >
TherapeuticsMD (TXMD)
NASDAQ:TXMD
US Market

TherapeuticsMD (TXMD) Financial Statements

Compare
2,240 Followers

TherapeuticsMD Financial Overview

TherapeuticsMD's market cap is currently $11.69M. The company's EPS TTM is $-0.189; its P/E ratio is ―; TherapeuticsMD is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 1.30M$ 69.96M$ 86.95M$ 64.87M
Gross Profit$ 0.00$ 1.30M$ 68.57M$ 68.11M$ 48.90M
Operating Income$ -4.76M$ -8.52M$ 20.14M$ -139.77M$ -155.54M
EBITDA$ -1.83M$ -8.40M$ 11.86M$ -78.57M$ -149.47M
Net Income$ -2.18M$ -10.28M$ 112.00M$ -205.60M$ -212.70M
Balance Sheet
Cash & Short-Term Investments$ 5.06M$ 4.33M$ 38.07M$ 65.12M$ 80.49M
Total Assets$ 38.82M$ 43.31M$ 90.46M$ 169.47M$ 181.61M
Total Debt$ 5.54M$ 8.01M$ 8.76M$ 196.33M$ 246.37M
Net Debt$ 483.00K$ 3.68M$ -29.31M$ 131.21M$ 165.89M
Total Liabilities$ 11.45M$ 14.02M$ 55.31M$ 263.09M$ 305.61M
Stockholders' Equity$ 27.37M$ 29.29M$ 35.14M$ -93.62M$ -124.00M
Cash Flow
Free Cash Flow$ 1.17M$ -48.14M$ -4.43M$ -144.92M$ -161.07M
Operating Cash Flow$ 1.17M$ -48.14M$ -4.08M$ -142.69M$ -159.47M
Investing Cash Flow$ 0.00$ 0.00$ 223.48M$ -2.22M$ -1.60M
Financing Cash Flow$ 0.00$ 3.15M$ -235.21M$ 129.55M$ 80.72M
Currency in USD

TherapeuticsMD Earnings and Revenue History

TherapeuticsMD Debt to Assets

TherapeuticsMD Cash Flow

TherapeuticsMD Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis